Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA A Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
Bukavina L, Bensalah K, Bray F et al (2022) Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 82:529–542. https://doi.org/10.1016/j.eururo.2022.08.019
Morkos J, Porosnicu Rodriguez KA, Zhou A et al (2020) Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology 296:452–459. https://doi.org/10.1148/radiol.2020192325
Bhagavatula SK, Tuncali K, Shyn PB et al (2020) Percutaneous CT- and MRI-guided cryoablation of cT1 renal cell carcinoma: intermediate- to long-term outcomes in 307 patients. Radiology 296:687–695. https://doi.org/10.1148/radiol.2020200149
Buy X, Lang H, Garnon J et al (2013) Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Am J Roentgenol 201:1353–1361. https://doi.org/10.2214/AJR.13.11084
Murray CA, Welch BT, Schmit GD et al (2019) Safety and efficacy of percutaneous image-guided cryoablation of completely endophytic renal masses. Urology 133:151–156. https://doi.org/10.1016/j.urology.2019.08.005
De Marini P, Cazzato RL, Garnon J et al (2021) Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. Diagn Interv Imaging 102:531–538. https://doi.org/10.1016/j.diii.2021.04.002
Garnon J, Van Strijen MJ, Nielsen TK et al (2019) Safety of percutaneous renal cryoablation: an international multicentre experience from the EuRECA retrospective percutaneous database. Eur Radiol 29:6293–6299. https://doi.org/10.1007/s00330-019-06191-y
Article CAS PubMed Google Scholar
Campbell SC, Clark PE, Chang SS et al (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol 206:199–208. https://doi.org/10.1097/JU.0000000000001911
Ljungberg B, Albiges L, Abu-Ghanem Y et al (2022) European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82:399–410. https://doi.org/10.1016/j.eururo.2022.03.006
Aoun HD, Littrup PJ, Jaber M et al (2017) Percutaneous cryoablation of renal tumors: Is it time for a new paradigm shift? J Vasc Interv Radiol 28:1363–1370. https://doi.org/10.1016/j.jvir.2017.07.013
Deng W, Chen L, Wang Y et al (2019) Cryoablation versus partial nephrectomy for clinical stage T1 renal masses: a systematic review and meta-analysis. J Cancer 10:1226–1236. https://doi.org/10.7150/jca.28881
Article CAS PubMed PubMed Central Google Scholar
Breen DJ, King AJ, Patel N et al (2018) Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289:554–561. https://doi.org/10.1148/radiol.2018180249
Gunn AJ, Joe WB, Salei A et al (2019) Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical outcomes. Cardiovasc Intervent Radiol 42:970–978. https://doi.org/10.1007/s00270-019-02226-5
Article PubMed PubMed Central Google Scholar
Uhlig J, Kokabi N, Xing M, Kim HS (2018) Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes. Radiology 288:889–897. https://doi.org/10.1148/radiol.2018172960
Pierorazio PM, Johnson MH, Patel HD et al (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol 196:989–999. https://doi.org/10.1016/j.juro.2016.04.081
Article PubMed PubMed Central Google Scholar
Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113:2671–2680. https://doi.org/10.1002/cncr.23896
Littrup PJ, Ahmed A, Aoun HD et al (2007) CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol 18:383–392. https://doi.org/10.1016/j.jvir.2006.12.007
Cazzato RL, De Marini P, Leonard-Lorant I et al (2021) Safety and oncologic outcomes of magnetic resonance imaging-guided cryoablation of renal cell carcinoma: a 10-year single-center experience. Invest Radiol 56:153–162. https://doi.org/10.1097/RLI.0000000000000719
Garnon J, Cazzato RL, Caudrelier J et al (2019) Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol 42:344–357. https://doi.org/10.1007/s00270-018-2089-7
Tsoumakidou G, Buy X, Garnon J et al (2011) Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol 14:170–176. https://doi.org/10.1053/j.tvir.2011.02.009
Khan F, Ho AM, Jamal JE et al (2018) Long-term outcomes after percutaneous renal cryoablation performed with adjunctive techniques. Clin Imaging 50:62–67. https://doi.org/10.1016/j.clinimag.2017.12.003
Patel IJ, Rahim S, Davidson JC et al (2019) Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—part ii: recommendations. J Vasc Interv Radiol 30:1168-1184.e1. https://doi.org/10.1016/j.jvir.2019.04.017
Kutikov A, Uzzo RG (2009) The renal nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853. https://doi.org/10.1016/j.juro.2009.05.035
Filippiadis DK, Binkert C, Pellerin O et al (2017) Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol 40:1141–1146. https://doi.org/10.1007/s00270-017-1703-4
Article CAS PubMed Google Scholar
Georgiades CS, Rodriguez R (2014) Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 37:1494–1499. https://doi.org/10.1007/s00270-013-0831-8
Blute ML Jr, Okhunov Z, Moreira DM, George AK, Sunday S, Lobko II, Vira MA (2013) Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int 111(4):E181–E185. https://doi.org/10.1111/j.1464-410X.2012.11538.x
Marion JT, Schmitz JJ, Schmit GD et al (2020) Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumor cryoablation. J Vasc Interv Radiol 31:1249–1255. https://doi.org/10.1016/j.jvir.2019.11.039
Yamagami T, Yoshimatsu R, Kajiwara K et al (2019) Protection from injury of organs adjacent to a renal tumor during percutaneous cryoablation. Int J of Urol 26:785–790. https://doi.org/10.1111/iju.14013
Weiss J, Garnon J, Cazzato RL et al (2021) Percutaneous hydrodissection for thermoprotection during cryoablation of periureteric and pyeloureteric junction renal cell carcinomas. Abdom Radiol 46:1179–1187. https://doi.org/10.1007/s00261-020-02760-8
Morgan AI, Doble A, Davies RJ (2012) Successful conservative management of a colorenal fistula complicating percutaneous cryoablation of renal tumors: a case report. J Med Case Reports 6:365. https://doi.org/10.1186/1752-1947-6-365
Wysocki JD (2010) Colo-renal fistula: an unusual cause of hematochezia. WJGP 1:106. https://doi.org/10.4291/wjgp.v1.i3.106
留言 (0)